NEW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection ...

The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction ...

The answer is very clear that if you have MI and preserved EF, there is no benefit of using a beta-blocker. Sripal Bangalore ...

Researchers are working on a redesigned pump that could offer hope for those with HFpEF, which accounts for about 32 million ...

A polypill containing three recommended heart failure therapies improved heart function, reduced hospitalizations and was ...

Yesterday at the Ernest N Morial Convention Center, latest clinical trial findings were disclosed on the use of human engineered heart muscle as biological ventricular assist tissue (BioVAT) ...

Long Beach Medical Center Cardiologists Pioneer Innovative Use of GLP-1 Agonists For decades, GLP-1 agonists—a class of medications including generic names like semaglutide and tirzepatide—have been ...

The study, which was simultaneously published in Circulation and presented as a Late-Breaking Clinical Trial at the American Heart Association Scientific Sessions, marked a significant step toward ...

A once-daily polypill containing 3 guideline-directed therapies for heart failure with reduced ejection fraction (HFrEF) led ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for ...

Trastuzumab emtansine is linked to a lower incidence of decrease in left ventricular ejection fraction than other trastuzumab ...